Cepheid Shares Lead Modest Gain for BCW Index | GenomeWeb
Shares of Cepheid rose 7.4 percent for the five-day trading period ended Tuesday. The firm’s stock closed up nearly 6 percent for Tuesday alone following a presentation by CEO John Bishop at the Piper Jaffray Health Care Conference in New York (see related article, this issue). 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.